CDK4/6 INHIBITOR

Clinical trials for CDK4/6 INHIBITOR explained in plain language.

Never miss a new study

Get alerted when new CDK4/6 INHIBITOR trials appear

Sign up with your email to follow new studies for CDK4/6 INHIBITOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New test could predict dangerous side effects of common breast cancer drugs

Knowledge-focused ENROLLING_BY_INVITATION

This study aims to develop a test to predict which breast cancer patients might experience severe side effects or poor response to a common class of drugs called CDK4/6 inhibitors. Researchers will analyze blood samples and genetic information from 100 female patients taking thes…

Matched conditions: CDK4/6 INHIBITOR

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Knowledge-focused

Last updated Mar 24, 2026 12:02 UTC

CDK4/6 INHIBITOR

Get alerted when new CDK4/6 INHIBITOR trials appear

New test could predict dangerous side effects of common breast cancer drugs